Lario Therapeutics Limited
Lario Therapeutics Limited
Trading as: Lario Therapeutics
#SC716204 • Active
B2bBiotechnologyServices
Lario Therapeutics is dedicated to developing first-in-class precision medicines aimed at modifying diseases associated with severe neurological disorders, including epilepsy and Parkinson's disease. Their innovative pipeline focuses on genetically validated targets to slow disease progression.
Founded: 26/11/2021
Industries: Research and experimental development on biotechnology
Website: https://lariotx.com
Phone: Subscribe to view
Email: Subscribe to view
Location: Edinburgh
Products
- Disease Modifying Treatments For Epilepsy
- Disease Modifying Treatments For Parkinson's Disease
Services
- Precision Medicines For Neurological Disorders
Financial Snapshot
Last accounts made up to 31 December 2023
Next accounts due 30 September 2025 (4 months)
Cash in Bank £0.37m
↓ -70%
Total Liabilities £5.29m
↑ 58%
Employees 1
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Peter Michael Finan | Director | 09/07/2024 | British | 57 years |
| Chiara Rossana Maria Liberati | Director | 01/06/2023 | Italian | 54 years |
| Henning Klaus-willi Christian Steinhagen | Ceo | 26/11/2021 | German | 55 years |
Role:
Director
Appointed:
09/07/2024
Nationality:
British
Age:
57 years
Role:
Director
Appointed:
01/06/2023
Nationality:
Italian
Age:
54 years
Role:
Ceo
Appointed:
26/11/2021
Nationality:
German
Age:
55 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality |
|---|---|---|---|
| Epidarex Capital Iii Uk, Lp | Ownership Of Shares 25 To 50 Percent, Voting Rights 25 To 50 Percent | 28/03/2022 | United Kingdom |
Nature of Control:
Ownership Of Shares 25 To 50 Percent, Voting Rights 25 To 50 Percent
Notified On:
28/03/2022
Nationality:
United Kingdom
Financial Accounts
| Dec 2023 | Dec 2022 | |
|---|---|---|
| Income Statement | ||
| Turnover | ||
| Export Revenue | ||
| Sales | ||
| Other Operating Income | ||
| Other Operating Items | ||
| Cost of Sales | ||
| Raw Materials & Consumables | ||
| Gross Profit | ||
| Admin Expenses | ||
| Other Operating Charges | ||
| Depreciation | ||
| R&D Expenses | ||
| Operating Profit | ||
| EBITDA | ||
| Financial Revenue | ||
| Financial Expenses | ||
| Financial Profit/Loss | ||
| Interest Paid | ||
| Extraordinary Revenue | ||
| Extraordinary Expenses | ||
| Net Extraordinary Items | ||
| Pre-Tax Profit | ||
| Tax | ||
| Profit After Tax | ||
| Retained Profit | ||
| Balance Sheet | ||
| Non-Current Assets | ||
| Intangible Assets | ||
| Tangible Fixed Assets | ||
| Other Non-Current Assets | ||
| Current Assets | ||
| Stock | ||
| Debtors | ||
| Cash in Hand | ||
| Other Current Assets | ||
| Called Up Share Capital | ||
| P&L Account Reserve | ||
| Shareholder Funds | ||
| Other Shareholder Funds | ||
| Provisions | ||
| Long Term Debt | ||
| Creditors (> 1 year) | ||
| Other Non-Current Liabilities | ||
| Short Term Debt | ||
| Creditors | ||
| Creditors (< 1 year) | ||
| Other Current Liabilities | ||
| Key Metrics | ||
| Net Assets | ||
| Net Current Assets | ||
| Total Assets Less Current Liabilities | ||
| Working Capital | ||
| Enterprise Value | ||
| Added Value | ||
| Cashflow Before D&A | ||
| Other Information | ||
| Staff Costs | ||
| Number of Employees | ||
Charges
No charges registered
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 07/04/2025 | Resolution | Resolution | View (2 pages) |
| 31/03/2025 | Capital | Second Filing Capital Allotment Shares | View (5 pages) |
| 31/03/2025 | Incorporation | Memorandum Articles | View (57 pages) |
| 28/03/2025 | Capital | Capital Allotment Shares | View (4 pages) |
| 04/12/2024 | Confirmation Statement | Confirmation Statement With No Updates | View (3 pages) |
| 14/07/2024 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
| 14/07/2024 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |